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Abstract 
Chromosomal translocations involving chimeric fusions of the nucleoporin NUP98 
protein have often been described in acute myelogenous leukemia (AML). All the 
fusion proteins have an identical NUP98 N-terminus, which contains the GLEBS motif 
for interaction with the mRNA export factor RAE1, and FG repeats that associate with 
the transcription factors HDAC1 and p300. It is virtually unknown whether these 
interaction partners affect leukemogenesis. We previously showed that RAE1 depletion 
caused aneuploidy, which enhanced tumorigenesis. We speculated that RAE1 may also 
be directly involved in NUP98 fusion-mediated leukemogenesis. We show here that 
RNA interference (RNAi)-mediated knockdown of NUP98 caused severe chromosome 
segregation defects and disrupted RAE1 but not HDAC1 expression and localization. 
Next, we performed rescue experiments to confirm that the RAE1-NUP98 complex 
orchestrates proper chromosome segregation. Interestingly, we found diverse behaviors 
of NUP98 and the leukemogenic fusion protein NUP98-HOXA9 throughout the cell 
cycle. Strikingly, in NUP98-HOXA9-transfected cells, RAE1 protein were reduced and 
mis-localized. Our cellular interpretations were further confirmed by NUP98-HOXA9 
transgenic mice and the NUP98-HOXA9 AML patient. These data suggest that RAE1 
orchestrates NUP98-mediated leukemogenesis and raise the possibility that targeting 
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this negative feedback loop may provide a new strategy for the therapy of aggressive 
leukaemias. 
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Introduction 
The nuclear pore complex (NPC) is composed of at least 30 different nucleoporins 
act as gatekeeper regulating transport between the cytoplasmic and nuclear 
compartments [1-5]. One of them, termed NUP98, which located on the chromosome 
11p15 have been repeatedly implicated in AML, chronic myelogenous leukemia, 
T-acute lymphocytic leukemia and in myelodysplastic syndrome (MDS) [6-8]. Over 
twenty genes have been reported as fusion partners of NUP98 in patients with leukemia 
[6]. All the disease-associated translocations involving NUP98 result in the fusion of the 
5′ end of NUP98 to the 3′ end of a partner gene. The fusion proteins that arise juxtapose 
the N-terminal FG (phenylalanine-glycine) repeats of NUP98, the presumed contact 
sites for another nucleoporin, RNA export factor 1 homolog (S. pombe) (RAE1) [9-12] 
and for the transcription factors histone deacetylase 1 (HDAC1) and CREB binding 
protein CBP/p300, to the C-terminus of the partner protein [13]. NUP98 fusions 
identified in patients frequently involve homeodomain transcription factors, most 
commonly HOXA9 [13]. NUP98-HOXA9 consists of amino acids 1–469 of NUP98 
joined to amino acids 163–271 of HOXA9; chimeric fusion proteins retain the 
C-terminal sequence of the transcription factor, including the 60-amino-acid homeobox, 
which is responsible for binding DNA [14]. Moreover, the NUP98-HOXA9 
translocation has been frequently observed in Asians, and the prognosis of patients with 
this aberration is poor [13, 14]. 
 A general cellular model for NUP98-homeodomain fusion-induced leukemogenesis 
cites aberrant transcriptional activation of novel target genes as the basis for cellular 
transformation [13, 15], but there is insufficient direct clinical evidence for this 
hypothesis [6-8, 16]. On the other hand, RAE1, a bona fide binding partner of NUP98 
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[17, 18], has been indicated as abnormal in breast [19, 20] and lung [21] cancer patients. 
We and others demonstrated that RAE1 is critical in the maintenance of spindle 
bipolarity: depleted RAE1 leading to chromosome instability and multipolar spindles, 
caused aneuploidy, which is often found in various cancers [10-12, 22]. An attractive 
possibility for NUP98 fusion-mediated leukemogenesis is that functional RAE1 is 
reduced in NUP98 leukemogenic fusion cells. This would enhance supernumerous 
spindle pole formation/multiple centrosomes, which would enhance tumorigenesis. This 
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Results 
RAE1 and NUP98 is involved in regulating proper chromosome segregation to prevent 
aneuploidy formation 
Before testing our hypothesis that RAE1 may contribute to NUP98-HOXA9 
leukemogenesis, we first tested whether altering endogenous NUP98 levels would affect 
RAE1 localization and expression, using knockdown by small interfering RNA (siRNA). 
Quantitative immunoblot analysis of HeLa cells subjected to NUP98 siRNA treatment 
for 72 h revealed a ~75% reduction in NUP98 compared with control cells (p < 0.05) 
(Figure 1A, upper panel). In siRNA-mediated NUP98-knockdown HeLa cells, we found 
that RAE1 protein levels were decreased by 70%, whereas the amounts of other 
nucleoporins (Tpr and p62) or HDAC1 (Figure 1A, B and Supplementary information, 
Figure S1A-C) and tubulin (as a loading control) were largely unaltered (Figure 1A). 
Furthermore, identical results were obtained in two leukemia cell lines (K562 and KG1) 
(Supplementary information, Figure S1D-G). To confirm that the observed reduction in 
the expression of RAE1 was not artifactual, and to assess RAE1 localization in 
NUP98-depleted HeLa cells, we performed immunostaining using antibodies against 
NUP98 and RAE1 in interphase cells. Notably, depletion of NUP98 abolished the 
expression and localization of RAE1 at the nuclear rim during interphase (Figure 1C, 
indicated by a white circle), in contrast to the NUP98 and RAE1 endogenous expression 
pattern observed with control siRNA (Figure 1C, upper panel). Using DAPI staining to 
monitor nuclear/chromatin alterations, we found that the frequency of “small-nuclei” 
(sized were 30% reduced compared with WT) was increased by 27% (n > 300 mitotic 
cells) in NUP98-depleted cells (Figure 1C). To test this “small-nuclei” notion further, 
we performed live cell imaging of NUP98 siRNA, control siRNA, or siRNA for another 
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nucleoporin, translocated promoter region (TPR), transfected into green fluorescent 
protein-histone H2B (GFP-H2B) stable cell lines. Abnormal nuclear/chromatin 
phenotypes were easy to observe in NUP98 siRNA GFP-H2B cell lines (Supplementary 
information, Figure S2B), but the same phenotypes were rarely found in control siRNA 
or TPR siRNA-transfected cells (Supplementary information, Figure S2A and C). Thus, 
these alterations in nuclear architecture likely reflect a role for NUP98 directly in 
forming nuclei or in influencing chromosomal dynamics during mitosis; deregulation of 
the latter process has previously been found to result in a very similar nuclear 
appearance [23, 24]. These data prompted us to speculate that NUP98 might contribute 
to chromatin/histone modifications; however, we did not find any change in the 
localization or expression of HDAC1, which binds NUP98 in the chromatin, in our 
routine protocols (Supplementary information, Figure S1H).  
 
We next sought to determine the consequences of NUP98 depletion on RAE1 
localization during mitosis. Interestingly, when NUP98 knockdown was incomplete, 
some RAE1 remained localized at the kinetochores and spindles (Figure 1D, white 
arrows) and most of the cells were bipolar with single rod-shaped chromosomes (by 
DAPI staining). On the other hand, in cells in which NUP98 was almost entirely 
depleted, RAE1 localization was abolished from kinetochores and spindles, and 
remarkable chromosome separation defects were found in 22% (Figure 1E). Particularly, 
NUP98 siRNA treatment of mitotic cells was consistently associated with abnormal 
congression of chromosomes at the metaphase plate. More than 22% of HeLa cells 
showed separation defects, whereas these defects were not found in control 
siRNA-treated cells (Figure 1 D and E, white circle). The reduction of NUP98 by RNAi 
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also led to the formation of multipolar spindles. We quantified the mitotic defects 72 h 
after transfection with siRNA targeting NUP98 and found that a high proportion (~30%) 
of cells displayed strikingly altered spindle morphology compared with control 
siRNA-transfected cells (n > 300 mitotic cells) (Figure 1E, F and Supplementary 
information, Figure S3). To investigate the chromosome separation defects further, we 
performed live cell imaging of NUP98 siRNA or control siRNA transfected into 
GFP-tubulin or GFP-H2B stable cell lines. Defective chromosome phenotypes in 
NUP98 siRNA GFP-H2B cells (Supplementary information, Figure S4B), and 
multipolar spindles in NUP98 siRNA GFP-tubulin cells (Supplementary information, 
Figure S4D), were clearly observable; however, they were rarely found during live 
imaging of control siRNA cells (Supplementary information, Figure S4A and B). To 
verify that the observed phenotypes were attributable specifically to disruption of 
NUP98 protein levels, and to determine whether the mitotic roles of NUP98 could be 
uncoupled, we performed RNAi-resistant NUP98 rescue experiment by overexpressing 
GFP-NUP98 in NUP98 siRNA cells. Forty-eight hours after transfection of 
GFP-NUP98 into NUP98 siRNA cells, we were able to visualize GFP signals and score 
the mitotic cells. We found that multipolar spindles/chromosome defects were partially 
rescued (n > 300 mitotic cells) (Figure 1G), indicating that these phenotypes result 
specifically from alterations in the level of NUP98. Together, these results suggest that 
NUP98, working together with RAE1[10, 11], is involved in regulating proper 
chromosome segregation to prevent aneuploidy. 
 
RAE1 interacts with GLEBS domain of N terminal of NUP98 and NUP98-HOXA9 
leukemic fusion proteins. 
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The above depletion experiments prompted us to explore whether exogenously 
overexpressed NUP98 also altered RAE1 functions. Because the N-termini of NUP98 
leukemogenic fusion proteins retain the GLEBS domain for RAE1 interaction [18], we 
wanted to test whether RAE1 directly influences leukemia formation. We first 
co-expressed FLAG-RAE1 with NUP98, NUP98-HOXA9 or HOXA9 (Figure 2A) in a 
cell-free reticulocyte translation system. Consistent with our predictions, NUP98 and 
the NUP98-HOXA9 fusion, but not HOXA9, interacted directly with RAE1 (Figure 2A). 
We then performed direct binding assays by loading glutathione-S-transferase (GST), 
GST-NUP98-N1–505 or GST-NUP98-C506–920 fragments mixed with in vitro-translated 
FLAG-RAE1 proteins. After extensive washing, the bound fraction was analyzed by 
western blotting to detect FLAG-RAE1. Consistent with a recent report [18], the 
N-terminal fragment GST-NUP98-N1–505, but not the C-terminal fragment 
GST-NUP98-C506–920, interacted directly with RAE1 (Figure 2B). GST alone was used 
as a control and did not bind to RAE1. The N-terminal fragment of NUP98 contains a 
GLEBS motif for RAE1 binding. To confirm the fine mapping between NUP98GLEBS 
and RAE1, we expressed FLAG-RAE1 in a cell-free reticulocyte translation system and 
pulled it down with wild-type (WT) (GST-NUP98 N1–505_GLEBS(WT)) or mutant 
(GST-NUP98 N1–505_GLEBS-(E201K/E202K)) NUP98 GLEBS domain constructs or GST alone 
(control). As shown in Figure 2C, Rae1 was specifically pulled down by GST-NUP98 
N1–505_GLEBS(WT). To test for interaction with Rae1 in vivo, we further expressed these 
fragments with GFP tags, GFP-NUP98 N1–505_GLEBS(WT), or GFP-NUP98 
N1–505_GLEBS-(E201K/E202K), or an empty GFP-vector in HEK 293T cells. As shown in 
Figure 2D, Rae1 was specifically pulled down by GFP-NUP98 N1–505_GLEBS(WT), but not 
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by GFP-NUP98 N1–505_GLEBS-(E201K/E202K) or an empty GFP vector. These data 
demonstrated that the mutant NUP98 N1–505_GLEBS-(E201K/E202K) did not bind RAE1. The 
GLEBS ending region is sufficient for RAE1 binding (Figure 2 C and D). These 
biochemical mapping data also imply that RAE1 binds directly to the ending region of 
the GLEBS binding site of NUP98, which is present in all NUP98 leukemogenic fusion 
proteins. 
 
We next examined the sub-cellular localization of the NUP98 and NUP98-HOXA9 
proteins together with RAE1 during the cell cycle, by transfecting hemagglutinin 
(HA)-tagged NUP98 and NUP98-HOXA9 cDNAs into HeLa cells. Lowly expressed 
transfected proteins with the HA tag were visualized by immunostaining and DAPI 
staining, immunostaining with or without NUP98 antibody (Supplementary information, 
Figure S5A and B) or RAE1 antibody (Figure 2E and F). Our findings were in 
accordance with previous reports that RAE1 was localized on the spindles/kinetochores 
during metaphase (Figure 2E and F)[11, 12, 22]. Interestingly, we found that during the 
metaphase-anaphase transition, the leukemogenic fusion protein NUP98-HOXA9 
appeared as punctate dots associated with chromatin (Figure 2F, and Supplementary 
information, Figure S5C), whereas NUP98 was found diffusely throughout the 
cytoplasm, was not associated with chromatin and was only partially associated with 
RAE1 (Figure 2E, white arrow). These observations suggest that the NUP98-HOXA9 
fusion disturbed the normal NUP98 nuclear rim localization, even with the N-terminal 
FG repeats intact. We found that the RAE1 immunofluorescence signals were generally 
weaker in transfected HA-NUP98-HOXA9 cells than in HA-NUP98-transfected cells. 
However, our HA antibodies could not differentiate clearly between HA-NUP98 and 




Expression of exogenous NUP98-HOXA9 robustly reduced RAE1 expression in HeLa, 
MCF7 and K562 cell lines. 
 
To verify the effect of NUP98 or NUP98-HOXA9 overexpression on RAE1 
distribution and expression, we generated visible GFP-tag constructs, GFP-HA-NUP98 
and GFP-HA-NUP98-HOXA9, and transfected them into HeLa cells (Figure 3A and B). 
Strikingly and completely unexpectedly, in triplicate confocal microscopy experiments, 
quantified using Image J software (n > 300 transfected mitotic cells), we found that 
RAE1 levels were robustly reduced in highly expressing GFP-NUP98-HOXA9 HeLa 
cells (Figure 3C and H) and the human breast adenocarcinoma cell line, MCF7 (Figure 
3D) and more importantly, the leukemia cell line, K562 (Figure 3E) comparing to a 
much lesser extent in GFP-NUP98 cells (Supplementary information, Figure S6A-C). 
Both of highly transfected GFP-NUP98-HOXA9 or GFP-NUP98 cells were elevated 
chromosome defects significantly (Figure 3F and G). Interestingly, we repeatedly 
observed that some of RAE1 resulted in a punctate distribution on the chromosomes in 
those GFP-NUP98-HOXA9 cells which was rarely found in GFP-NUP98 chromosome 
defects cells; and some of NUP98-HOXA9 (indicated as GFP fluorescence signals) 
were pulled out from chromosomes (Figure 3F and G) compared with low transfected 
NUP98-HOXA9 localization (Figure 2F). These data indicated that transient altered 
localization patterns between RAE1 and NUP98-HOXA9 elevated chromosome 
instability leading to aneuploidy during cell division. Moreover, immunoprecipitation 
with anti-GFP (Figure 3B) from HeLa and leukemia K562 cell lysates expressing GFP, 
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GFP-NUP98 or GFP-NUP98-HOXA9 further confirmed the reduction of RAE1 protein 
(Figure 3H and Supplementary information, Figure S6D). We further quantitated 
(relative %) the relative RAE1 fluorescence intensity, we found that RAE1 was 
significantly also reduced (p<0.05) in GFP-NUP98-HOXA9 (Figure 3I) but not in 
GFP-NUP98-transfected HeLa and MCF7 cells (Supplementary information, Figure 
S6E). Taken together, these results suggest that RAE1 might be a crucial marker in 
overexpressed NUP98-HOXA9 leukemogenic fusion cells. 
 
Reduced RAE1 expressions are also found in the spleen of NUP98-HOXA9 transgenic 
mice and in the bone marrow of NUP98-HOXA9 AML patient 
To confirm our cellular observations (Figure 3C-G) and our speculation that the 
reduction in RAE1 in NUP98-HOXA9 fusions is critical to leukemogenesis, we 
investigated NUP98-HOXA9-expressing transgenic mice. Consistent with a previous 
report [25, 26], histological examination of leukemic NUP98-HOXA9 transgenic 
animals revealed that megakaryocytic cells were frequently found in the spleen; this was 
seldom observed in WT littermates and non-leukemic NUP98-HOXA9 transgenic mice 
(Figure 4A). Consistently, we found that RAE1 and endogeneous NUP98 expression 
was reduced in those multinucleated megakaryocytic spleen cells of NUP98-HOXA9 
transgenic mice (3 independent transgenic lines), but not in WT mice by 
immunoblotting, in triplicate experiments. The same membrane was re-probed with 
β-actin as a loading control (Figure 4B). Interestingly, low RAE1 expression was 
restricted to the multinucleated megakaryocytic spleen cells that were observed only in 
NUP98-HOXA9 leukemic transgenic mice by confocal microscopy (Figure 4C and D 
and Supplementary information, Figure S6F).  
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To further strengthen our hypothesis that RAE1 is involved in NUP98 
fusion-mediated leukemogenesis, we systematically investigated the bone marrow of 52 
Chinese AML and MDS patients, representative 6 of them were shown in Figure 4E 
(and also Supplementary information, Table S2). By RT-PCR from bone marrow cells, 
we identified one AML patient with a NUP98-HOXA9 translocation. Consistent with 
our results in cellular and rodent models, RAE1 and endogeneous NUP98 mRNA levels 
were dramatically reduced in the bone marrow of this NUP98-HOXA9 patient (Figure 
4F and G), but were unaltered in others. 
 
HOXA9 binds to RAE1 promoter region in NUP98HOXA9 mice and other leukemia cell 
lines 
 
Finally, since NUP98–HOXA9 initiates transformation through HOXA9-mediated 
DNA binding and transcription, to test whether HOXA9 could bind the RAE1 promoter 
and modulate its expression, we used GenBank and GenAge [27] databases, mining the 
RAE1 transcription promoter region. Strikingly, we found that RAE1 contains a 
HOXA9 consensus sequence, GATTTAT [28, 29] (Supplementary information, Figure 
S7A). Because NUP98–HOXA9 initiates transformation through HOXA9-mediated 
DNA binding and transcription, we tested whether HOXA9 could bind the RAE1 
promoter and activate its expression directly. On the basis of ChIP (Chromatin 
immunoprecipitation) assays from HOXA9, we further demonstrated that the 
transcription factor HOXA9 also directly participate in the regulation of RAE1 in 
NUP98-HOXA9 transgenic mice derived cell lines or other leukemia or cancer cell lines 
(Supplementary information, Figure S7B). Finally, consistent confirmation from some 
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of recent microarray analyses revealed that RAE1 gene expression is low in AML 
patients [30, 31] compared with controls (http:www.oncomine.org) [32]. These CHIP 
assay and proteomic data further show that RAE1 can be regulated by NUP98–HOXA9 
and subsequently contribute to leukemogenesis. 
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Discussion 
At first glance, our data showing nucleoporin RAE1 is involved in NUP98-HOXA9 
leukemogenesis. RAE1 and NUP98 are components of the NPC facilitating mRNA 
export during interphase. HOXA9 is a member of the homeobox family, playing an 
regulatory role in the self-renewal of hematopoiesis [6, 33]. Expression of exogenous 
NUP98-HOXA9 in murine bone marrow resulted in myeloproliferative disease 
progressing to AML by 8 months [25, 26], and enhanced stem cell proliferation [34]. 
The current model of NUP98 leukemogenesis has focused on mis-regulation of 
transcription due to coupling of DNA binding through the homeodomain to the 
recruitment of chromatin-modifying co-regulators by the NUP98 FG repeats [7, 13, 15]. 
This combination of activities leads to upregulation of homeodomain target genes, such 
as HOXA9 or MEIS. However, there is insufficient direct clinical evidence for this 
hypothesis [15]. Here we provide an alternative model whereby NUP98 fusion causes 
chromosome segregation defects during mitosis together with RAE1 (Supplementary 
information, Figure S8). The two models are not necessary mutually exclusive. 
 
We first confirmed the RAE1-NUP98 interaction (Figure 2A–D) and defined their 
functional relationship throughout the cell cycle (Figure 1C and D). Our RNAi NUP98 
depletion assays and rescue experiments clearly showed that knockdown of NUP98 
remarkably reduced RAE1 activity. Our data suggest that NUP98, working together 
with RAE1, is involved in regulating proper chromosome segregation to prevent 
aneuploidy. 
 
We also demonstrated the dramatic differences between NUP98 and NUP98-HOXA9 
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leukemogenic fusions during mitosis (Figure 2E and F). Endogenous NUP98 was 
localized diffusely throughout the cells. Remarkably, NUP98-HOXA9 was concentrated 
at the chromosome arms and kinetochores. It is a recurrent theme in AML that fusion 
proteins acquire novel intranuclear localizations as well as novel activities [15]. During 
metaphase, low-level GFP-NUP98-HOXA9 was expressed in a fine punctate pattern 
concentrated on the chromosome arms and kinetochores. This localization pattern was 
clearly distinct from that of WT proteins (Figure 2E and F). Besides, NUP98-HOXA9 
was not found at the NPC; one possibility is that the N-terminal binding interactions 
through the nucleoporin repeats of NUP98 act synergistically to generate novel protein 
targeting and other functions that lead to leukemogenic transformation [7, 13]. 
Interestingly, NUP98 depletion showed that nuclei/chromatin sizes were generally 
smaller than those of non-depleted cells (Figure 1C). The size of nucleus is usually 
proportional to the size of the cell itself [35]. Recent studies indicated that another 
NUP98 binding partner Karyopherins/importin-α is actively involved[36]. Whether 
NUP98 directly regulates nuclear size or not need further investigation. Besides, NUP98 
might be involved in histone modification in other ways, because NUP98-JARID1A 
was recently reported to bind specifically to trimethylated histone H3K4 [37, 38]. 
However, there are no known H3-specific binding sites in either NUP98 or 
NUP98-HOXA9. Whether NUP98-HOXA9 regulates transcription via histone 
modifications will also require further investigation. 
 
Our study also demonstrates that reduced the expression level of endogenous NUP98 
protein in megakaryocytic NUP98-HOXA9 transgenic mice (Figure 4A-D) and 
NUP98-HOXA9 mRNA in the bone marrow of an AML patient (Figure 4E-G). Because 
 17 / 36 
 
of the heterozygous nature of NUP98 translocations in leukemia patients and the lack of 
detectable fusion protein at the NPC, the NPC in these patients is presumably deficient 
in NUP98. Such a 30–50% reduction in NUP98 protein levels could seriously affect the 
normal function of RAE1 and/or NUP98. In addition, Gle2, the yeast homolog of RAE1, 
and NUP116 (homolog of human NUP98) are required for NPCs with abnormal 
morphology. Knock-out either one generates pore with a membrane dome that are 
incompetent of nucleocytoplasmic transport [17, 39]. In fact, our data support this 
notion (Figures 1 and 3). In particular, in wholly depleted NUP98 cells, RAE1 
localization and expression were entirely disrupted and caused serious mitotic errors 
(Figure 1D and Supplementary information, Figure S4) which enhanced aneuploidy 
formation. With these detailed in vitro, rodent and human clinical data, we proposed a 
tentative model (negative feedback loop) to explain how RAE1 contributed in NUP98 
fusion-mediated leukemogenesis (Supplementary information, Figure S8). We suggest 
that overexpression of the NUP98 leukemogenic fusion protein (e.g., NUP98-HOXA9) 
causes a reduction in endogenous NUP98. NUP98 reduction also leads to a disruption in 
RAE1 localization and function during interphase and cell division (Figure 1 and 
Supplementary information, Figure S1-4). We found that RAE1 depletion led to 
aneuploidy (Figure 1D–F and Supplementary information, Figure S3-4) and caused 
spindle and chromosome segregation defects and the formation of multiple centrosomes, 
thereby activating leukemogenesis [40-42] (Supplementary information, Figure S3). 
The kinetics of AML formation is influenced by many other components that will likely 
modify the effects we reported here for Rae1 and NUP98-HOXA9.  
In summary, our cellular findings are in excellent agreement with our rodents and 
human clinical data on the expression of, and interaction between, RAE1 and NUP98. 
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These data clearly demonstrate that RAE1 is actively involved in NUP98 
fusion-mediated leukemogenesis.  
Materials and Methods 
 
Plasmid construction 
The plasmid encoding full-length human NUP98, tagged with GFP, was a kind gift from 
Dr. Nabeel Yaseen (Washington University School of Medicine). Two fragments of 
NUP98 (N and C) were subcloned by PCR from pcDNA3-NUP98 into pET28a-GST, 
(pET28a modified to contain a N-terminal GST together with an N-terminal His6 tag). 
For the generation of EGFP and HA-tagged NUP98 expression plasmid, a cDNA 
encoding full length NUP98 tagged with HA were futher subclone into pEGFPC2 vector. 
The details of expression constructs and cloning primers are listed in Supplementary 
information, Table S1A and B. All constructs were confirmed by DNA sequencing. 
Sequence analyses were performed at the DNA sequencing facility of the Kanazawa 
University Cancer Research Institute using a PRISM3100-AvantGenetic Analyzer 
(Applied Biosystems). DNA and protein data bases were searched using the BLAST or 
BLAT search algorithms at the NCBI.  
 
Mammalian Cell Culture, Transfections, and Synchronization 
HeLa, HEK293T, MCF-7, K562, and KG1 cells were obtained from the American Type 
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Culture Collection (ATCC) and were synchronized in S phase by double thymidine 
block using 2mM thymidine for mitotic cell collection, if necessary. Cells were 
transfected with plasmids using Turbofect, following the manufacturer’s protocol 
(Fermentas). The HeLa GFP-H2B or GFP-α-tubulin cell line was generated by 
transfection of GFP-H2B or GFP-α-tubulin cDNA to HeLa cells respectively; and 
maintained in G418 (600 μg/ml). The HeLa GFP-H2B or GFP-α-tubulin cell line was 
used for analysis of mitotic progression. 
 
RNA interference 
siRNA duplexes targeting NUP98 (sc-43535) and control siRNA (sc-37007) were 
purchased from Santa Cruz Biotechnology. siRNA transfections were performed using 
Lipofectamine 2000, following the manufacturer’s protocol (Invitrogen). HeLa cells 
were transfected 24 h before the initiation of the first thymidine block and collected or 
imaged 72 h after transfection. If necessary, transfection efficiency was monitored with 
Block-iT (Invitrogen). 
 
Antibodies, Immunocytochemistry, and Confocal Microscopy 
α-RAE1 and α-NUP98 polyclonal antibody were from Dr. Gunter Blobel (Rockefeller 
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University). Secondary antibodies were from GE and Molecular Probes. The details of 
antibody usages and dilutions were listed in Supplementary information, Table S1C.  
For immunofluorescence, synchronized HeLa cells were washed in phosphate-buffered 
saline (PBS) and fixed for 10 min in 4% paraformaldehyde in PBS. Cells were then 
permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature. Samples 
were mounted onto coverslips with Pro- Long Gold Antifade reagent (Invitrogen) and 
were examined on a Zeiss LSM5 EXCITER confocal microscope, and all images were 




For NUP98 immunoprecipitations(IP),~107 cells were seeded and synchronized as 
described above. Mitotic HeLa cells were collected, washed with PBS, spun at 400×g 
for 10 min, and lysed in 1 ml of cold lysis buffer (50 mM Tris-HCl (pH 7.2), 250 mM 
NaCl, 0.1% NonidetP-40, 2mM EDTA, 10% glycerol) containing 1×protease inhibitor 
mixture (Roche Applied Science) and 1mM phenylmethylsulfonyl fluoride. Lysates 
were centrifuged for 30 min at 4 °C at 14,000 × g. The resulting lysate supernatants 
were precleared with 50 μl of protein A/G bead slurry (Santa Cruz Biotechnology), 
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mixed with 10 μl of various antibodies as specified, and incubated for 1 h at 4 °C with 
rocking. The beads were then washed five times with 500μl of lysis buffer. After the last 
wash, 50 μl of 1× SDS-PAGE blue loading buffer (New England Biolabs) was added to 
the bead pellet before loading. 
 
Expression of Recombinant Proteins 
For expression of NUP98 fragments, Escherichia coli BL21(DE3)-Condon plus cells 
and pLys cells (Stratagene) were grown at 37 °C to an A600 of 0.6 and induced with 0.5 
mM isopropyl-β-D-thiogalactopyranoside at 18 °C for 7 h. The cells were harvested by 
centrifugation and lysed in buffer containing 50mM Tris-HCl (pH 7.7), 150mM KCl, 
0.1% Triton-X100, 1 mM phenylmethylsulfonyl fluoride, and Complete EDTA-free 
protease inhibitor mixture tablets (Roche Applied Science). The cells were lysed with a 
cell sonicator (SMT), and the lysate was clarified by centrifugation at15,000× g for 60 
min. The proteins containing the GST tag were purified by glutathione affinity (GE 
Healthcare). 
 
Biochemical “Cell-free” Binding Assays 
Proteins were expressed using the Promega TNT coupled transcription/translation 
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system according to the manufacturer’s protocol. Each GST-tagged protein was loaded 
onto glutathione-agarose beads (GE Healthcare) in lysis buffer (50 mM Tris-HCl (pH 
7.7), 150 mM KCl, 0.1% Triton-X100, 1×protease inhibitor mixture) for 1 h at 4 °C. 
The beads were washed with wash buffer (50 mM Tris-HCl (pH 7.7), 300mM KCl) and 
incubated with in vitro translated proteins for 2 h at 4 °C. The beads were then washed 
five times with wash buffer. After the last wash, 1 × SDS-PAGE blue loading buffer was 
added to the beads before loading. 
 
Time-lapse Microscopy 
Time-lapse analysis of histone dynamics during metaphase and anaphase transition in 
live cells was recorded by GFP-H2B or GFP-α-tubulin stable cell lines. Cells were 
placed in a microincubation chamber (7136; Corning) on the stage of a Zeiss LSM5 
confocal microscope, which was heated to 37 °C and equipped with CO2 supply 
(Electric CO2 Microscope Stage Incubator; OKO Lab). Time-lapse series were 
generated by collecting photographs every 3 min; the photographs were then converted 
to 8-bit images and processed by Adobe Photoshop CS2 and Quick-Time software. 
 
Histological Analysis 
Mice (12 wks or above) were fixed in 10% Formalin Neutral Buffer solution (Wako). 
 23 / 36 
 
The spleen tissues were then removed, washed, dehydrated in a graded series of ethanol, 
and embedded in Paraplast (Oxford Labware). The blocks were cut by using a rotatory 
microtome (HM355; Rotary Microtome Zeiss) and sectioned serially at 5 μm thickness 
by using the same microtome. They were mounted on glass slides, deparafinized, and 
stained with hematoxylin/eosin solution as described previously [43]. All of the animal 




The chromatin immunoprecipitation (ChIP) assay was performed using OneDay 
ChIPTM Kit (Diagenode Inc) according to the manufacturer's instructions with some 
modifications. Human KG1, K562, HeLa, and NUP98-HOXA9 transgenic mice derived 
cell lines (NH143 and T2539) (5 x 106) were cross-linked by adding 1% formaldehyde 
directly to the culture medium for 10 min at 37°C. The cells were then lysed with the 
lysis buffer supplied in the kit and sonicated at 4°C for five 10-s periods. Approximately 
1% of the resulting sample was kept to serve as an input genomic DNA control, and the 
rest was pre-cleared with salmon sperm DNA-protein A. Cell lysates were incubated 
with HOXA9 antibody (SC-17155; Santa Cruz Biotechnology) overnight at 4°C with 
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rotation, followed by a 2h incubation with protein A-agarose for ChIP. HOXA9 in the 
immunoprecipitate was detected by Western blotting. The precipitated 
chromatin-HOXA9 complex was washed and eluted, and cross-links were reversed by 
heating at 65°C for 4 h. The genomic DNA fragments, thus isolated, were purified 
followed the manufacturer's instructions and amplified by PCR. The PCR products were 
separated on a 2% agarose gel. The primer sets for PCR were designed to cover the 
regions of the RAE1 promoter. The primer sequences were 
5'-TTGGCCAGACTTGTCTTGAA-3' and 5'-GCCGCTGCAAGTTACTAAGC-3'.  
 
Patients 
All healthy adults and patients were diagnosed at West China Hospital, Sichuan 
University in 2009. All cases were diagnosed with bone marrow aspirates, blood smears, 
trephine biopsies, flow cytometry and/or cytogenetic analysis. Clinical parameters, 
hemogram data, and flow cytometry results at the time of diagnosis were reviewed. The 
diagnosis and classification of AML were based on the criteria established by the WHO. 
All the samples are collected with the approval of Sichuan University West China 
Hospital Research Ethnics Committee, and written informed consent was obtained from 
each subject. Patients with antecedent hematologic diseases or therapy-related AML 
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were excluded.  
One patient was the subject of this study. The 56-year old patient was referred to our 
hospital due to symptoms of ecchymosis and abnormal complete blood count. Physical 
examination revealed petechial and ecchymosis in skin. The measurements of peripheral 
blood values were as follows: hemoglobin 100g/L, platelets 23×109/L, and white blood 
cell count 2.3×109/L. The bone marrow (BM) aspirates were hypercellular, with 69% 
myeloblasts, 43% of which were strongly positive for myeloperoxidase. 
Immunophenotypic analysis showed that the blasts were positive for CD34 , HLA-DR, 
CD13,  CD33 , CD117 and CD56. A diagnosis of AML was made according to the 
World Health Organization criteria. The patient and her family give up any treatments 
after diagnosis due to economical reasons. For details, please see Supplementary 
information, Table S2. 
 
Detection of NUP98-HOXA9 fusion transcript. 
Total RNAs were extracted from bone marrow cells using Trizol method (Qiagen) 
according to the manufacturer’s instructions. A total of 2μg RNA was reverse 
transcribed at 42℃ for 1 h in 20μl reaction mixture containing Moloney murine 
leukemia virus reverse trancriptase kit (TAKARA). Serially twofold diluted cDNA 
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products were amplified for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
using a specific set of primers  using 25 cycles consisting of following reaction 
conditions: 94℃ for 30 s, 58℃ for 30 s and 72℃  for 1 min in a 25-μl of reaction 
mixture containing Taq polymerase (Roche) to evaluate the quantity of the transcribed 
cDNA. Equal quantities of cDNA products were then amplified for the indicated genes 
using the specific sets of primers (Supplementary information, Table S1B) with 35 
cycles consisting of following conditions: 94 °C for 30 s, 55 °C for 1 min and 72 °C for 
1 min. The resultant PCR products were fractionated on 1.5% agarose gel and 
visualized by ethidium bromide staining under ultraviolet light trans-illumination. The 
band intensities were measured using National Institutes of Health Image analysis 
software, version 1.62, and the ratios to GAPDH were calculated on the assumption that 
the ratios of the normal were set at 1.0. 
 
Statistical Analyses 
All data represent the average from at least three independent experiments, with at least 
100 cells counted per experiment. Significant were calculated by Student t-test. 
Differences were considered significant when p was < 0.05. Error bars represent mean ± 
S.D. of three different experiments. 
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Figure 1. Knockdown NUP98 abolished RAE1 localization and expression. 
(A)Effects of NUP98 depletion on protein levels of NUP98-associated proteins. Lysates 
of control siRNA and lysates of NUP98 siRNAs (NUP98 RNAi) in HeLa cells. 72 h 
after transfection were analyzed by immunoblotting (IB) with the indicated antibodies. 
The same membrane was stripped and re-probed with anti-α-tubulin (as loading control). 
Numbers indicate molecular masses markers in kilodaltons. (B)Quantitation 
(relative %) of relative expression of NUP98, RAE1 and HDAC1 in control siRNA and 
NUP98 siRNA-transfected (72hr) HeLa cells. Mean values ± S.D. (error bars) are 
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shown. (C)Representative images of interphase HeLa cells, transfected with either 
control siRNA duplex or NUP98 siRNA. 72 h after transfection, cells were stained with 
anti-NUP98 antibody (green) or RAE1 antibody (red) and analyzed by confocal laser 
microscopy respectively. Chromatin was stained with DAPI (blue). Scale bars, 10 μm. 
Normally, NUP98 displayed nuclear rim staining. During interphase, NUP98 was 
dramatically reduced at the nuclear rim signals, 72 h after transfection with 
NUP98-specific siRNAs. Nuclei size was relatively smaller in NUP98 depleted cells. 
White circle indicates a remained non-depleted NUP98 cell. (D)Pictorial presentation of 
various mitotic errors of mitotic HeLa cells, transfected with siRNA duplex against 
NUP98. 72 h after transfection, cells were stained with anti-NUP98 antibody (green) or 
RAE1 antibody (red) and analyzed by confocal laser microscopy. Chromatin was 
stained with DAPI (blue). Scale bars, 10 μm. Mitotic NUP98 was dramatically reduced 
at the kinetochores, 72 h after transfection with NUP98-specific siRNAs. White arrows 
indicate RAE1 kinetochore and spindle staining in a remained non-depleted NUP98 cell. 
White circle indicates typical chromosomes missegregation NUP98 depleted cells, 
RAE1 expression was also reduced in those mitotic NUP98 depleted cells. 
(E)Quantification of mitotic errors in control siRNA and NUP98 siRNA assays. Graph 
indicate the percentage of cells with abnormal spindles (counting from tubulin and/or 
pericentrin antibodies (refer to Supplementary information, Figure S3). Column, mean 
(n=3); Mean values ± S.D. (error bars) are shown. (F)Quantification of mitotic errors in 
control siRNA and NUP98 siRNA assays. Graph indicate the percentage of cells with 
abnormal monopolar (blue) and multipolar (brown) spindles (counting from tubulin 
and/or pericentrin antibodies (refer to Supplementary information, Figure S3). Column, 
mean (n=3); Mean values ± S.D. (error bars) are shown. (G)Quantification of mitotic 
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errors in control siRNA, NUP98 siRNA and cotransfection with NUP98 rescue assays. 
Mitotic HeLa cells were scored for abnormal spindles. The graph represents means of 
three independent experiments in which 100 mitotic cells were scored at each time. 
Graph indicates the percentage of cells with abnormal spindles (counting from tubulin 
and/or pericentrin antibodies (refer to Supplementary information, Figure S3). Column, 
mean (n=3); Mean values ± S.D. (error bars) are shown. 
 
Figure 2. RAE1 interacts with GLEBS domain of N terminal of NUP98 and also 
NUP98-HOXA9 leukemic fusion proteins. (A) Autoradiograph of [35S] 
methionine-labeled FLAG-RAE1 and NUP98-HOXA9, and NUP98-HOXA9 
coexpressed in vitro, affinity-purified with FLAG beads, and separated by SDS/PAGE 
respectively. (B) RAE1 (untagged) expressed in vitro, affinity-purified together with 
recombinant proteins of GST, GST-NUP98-N1-505, and GST-NUP98-C506-920, and 
separated by SDS-PAGE. Numbers on the bottom refer to amino acids; all fragments are 
continuous (e.g. NUP98-N ends at amino acid 505, and NUP98-C starts at amino acid 
506). RAE1 was prepared from TNT Quick-Coupled Transcription/translation system 
(Promega) together with TranscendTM Biotin-Lysyl-tRNA (Promega). Detection was 
done by streptavidin horseradish peroxidase (HRP) (1:4,000). (C) Examination of the 
interaction between RAE1 and GST-NUP98 GLEBS mutants. GST pull down assays 
indicated that the GLEBS is sufficient for RAE1 binding. A double mutant in GLEBS, 
E201K/E202K, abolishes the RAE1-NUP98GLEBS interaction. (D) In vivo pull down 
assays of GFP-tagged NUP98 fusions, GFP-NUP98 N1–505_GLEBS(WT), or GFP-NUP98 
N1–505_GLEBS-(E201K/E202K) and an empty GFP-vector in HEK 293T cells, followed by 
protein A/G beads-crosslinked anti-GFP IP and immunoblotting with anti-Rae1and 
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anti-GFP. (E, F) Representative images of mitotic HeLa cells transfected with plasmids 
overexpressing HA-NUP98 and HA-NUP98-HOXA9. 48 h after transfection, cells were 
fixed, stained anti-HA (green) and anti-RAE1 (red) antibodies for immunofluorescence 
visualization and examined by confocal microscopy. Chromatin was stained with DAPI 
(blue). Scale bars, 5 μm. White circles indicate different localization pattern between 
NUP98 and NUP98-HOXA9. White arrows indicate RAE1 spindle localization during 
metaphase. 
 
Figure 3. Expression of exogenous NUP98-HOXA9 robustly reduced RAE1 
expression in HeLa and MCF7 cell lines. (A) Schematic of the NUP98 and 
NUP98-HOXA9 expression plasmids with visible GFP tags. Numbers on the left refer 
to amino acids. (B) HeLa cells were transfected with a GFP-NUP98 or 
GFP-NUP98-HOXA9 expression plasmid. After 48 h, the cells were lysed and 
immunoprecipitation with an anti-GFP antibody and analyzed by immunoblotting with 
an anti-GFP antibody. Asterisks indicate the GFP fusion proteins.  (C-E) 
Representative images of C) HeLa cells, D) MCF7 cells and E) K562 cells transfected 
with plasmids overexpressing GFP-NUP98-HOXA9. 48 h after transfection, cells were 
fixed, stained with anti-RAE1 antibodies (red in overlay; GFP is green), and analyzed 
by confocal laser microscopy. Chromatin was stained with DAPI (blue). Scale bars, 10 
μm. (F-G) Representative images of mitotic HeLa cells transfected with plasmids 
overexpressing F) GFP-NUP98-HOXA9 and G) GFP-NUP98 respectively. 48 h after 
transfection, cells were fixed, stained with anti-RAE1 antibodies (red in overlay; GFP is 
green), and analyzed by confocal laser microscopy. Chromatin was stained with DAPI 
(blue). Scale bars, 5 μm. Some of RAE1 located in a punctate distribution on the 
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chromosomes in those highly expressed GFP-NUP98-HOXA9 cells (F)which was 
rarely found in highly expressed GFP-NUP98 chromosome defects cells (G). (H) 
Immunoprecipitates (IP) from mitotic HeLa cell and K562 cell (Supplementary 
information, Figure S6D) extracts (prepared same as in Figure 2G) with anti-GFP 
antibody was analyzed by SDS-PAGE, followed by immunoblotting with RAE1 
antibody. (I) Quantitation (relative %) of relative RAE1 fluorescence intensity in GFP, 
GFP-NUP98 GFP-NUP98-HOXA9 and GFP-HOXA9-transfected HeLa cells. Values 
are based on three independent experiments, counting 80 transfected cells in each 
experiment. Mean values ± S.D. (error bars) are shown. 
 
Figure 4. Reduced RAE1 expressions are found in the megakaryotic spleen of 
NUP98-HOXA9 transgenic mice and in the bone marrows of NUP98-HOXA9 AML 
patient. (A) Haematoxylin/erosin staining of spleen tissue from NUP98-HOXA9 
transgenic mice and its wild type (WT) littermate. Multinucleated spleen cells (indicates 
as black arrows) are often found in NUP98-HOXA9 transgenic mice but not its WT 
littermates. (B) RAE1 and endogeneous NUP98 (antibody only recognizes C-terminal 
of NUP98) immunoblot of WT and NUP98-HOXA9 transgenic mice spleen. The same 
membrane was stripped and reprobed with anti-β-actin (as loading control). (C) RAE1 
expression is reduced in NUP98-HOXA9 mice but not in WT. Representative 
immunostaining images of NUP98-HOXA9 trangenic mice and its WT littermate. 
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Spleen sells were fixed, stained with anti-RAE1 antibodies (green) and mb414 (red), 
and analyzed by confocal laser microscopy. Chromatin was stained with DAPI (blue). 
Scale bars, 10 μm. (D) RAE1 expression is robustly reduced in NUP98-HOXA9 mice 
megakaryotic spleen cells. Representative immunostaining images of NUP98-HOXA9 
trangenic mice and its WT littermate. Spleen sells were fixed, stained with anti-RAE1 
antibodies (green) and mb414 (red), and analyzed by confocal laser microscopy. 
Chromatin was stained with DAPI (blue). Scale bars, 10 μm. White arrow indicates 
RAE1 reduction compared with WT spleen cells. (E) Schematic diagram of NUP98 
endogeneous proteins and deduced chimeric protein after chromosomal translocation, 
and sequence of NUP98-HOXA9 fusion transcription junction. Horizontal arrows 
indicate the RT-PCR primers. (F) Reverse transcription-polymerase chain reaction 
(RT-PCR) analysis of sequential bone marrow samples taken from the patient’s bone 
marrow. Lane 1-2, RT-PCR products of non-leukemia patients; Lane 3-4 RT-PCR 
products of in AML patients ; Lane 5-6 RT-PCR product of MDS patients; Lane7, 
RT-PCR products of in AML patient; Lane 8, RT-PCR product of the AML patient with 
t(7;11) described. The 537 bp NUP98-HOXA9 fusion product was detected in AML 
patient (Lane8). (G) Quantitation (mean values of relative RAE1 intensity) of mRNA 
expression of RAE1 in patients bone marrow cells. Values are based on three 
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